BARCLAYS PLC - ESSA PHARMA INC ownership

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ESSA PHARMA INC
ValueSharesWeighting
Q3 2023$41,288
+128700.0%
0.00%
Q2 2022$0
-100.0%
1
-99.1%
0.00%
Q1 2022$1,000
-99.8%
112
-99.9%
0.00%
Q3 2021$618,00077,3000.00%
Other shareholders
ESSA PHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
Soleus Capital Management, L.P. 4,287,094$13,247,1201.22%
BVF INC/IL 8,748,629$27,033,2640.73%
PFM Health Sciences, LP 4,199,253$12,975,6920.61%
Bellevue Group AG 7,898,583$24,406,6210.39%
Rhenman & Partners Asset Management AB 356,500$1,101,5850.12%
Rock Springs Capital Management LP 677,005$2,091,9450.06%
Orbimed Advisors 842,366$2,602,9110.06%
Privium Fund Management (UK) Ltd 20,032$61,0980.05%
Hunting Hill Global Capital, LLC 10,000$30,9000.01%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,042,531$3,221,4210.01%
View complete list of ESSA PHARMA INC shareholders